產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時服務熱線
![NCI-H146 [H146] (人小細胞肺癌細胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0693-1.jpg)
![NCI-H146 [H146] (人小細胞肺癌細胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0693-2.jpg)
![NCI-H146 [H146] (人小細胞肺癌細胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0693-3.jpg)
![NCI-H146 [H146] (人小細胞肺癌細胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0693-4.jpg)
![NCI-H146 [H146] (人小細胞肺癌細胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0693-5.jpg)
![NCI-H146 [H146] (人小細胞肺癌細胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0693-7.jpg)
![NCI-H146 [H146] (人小細胞肺癌細胞) (STR鑒定正確)](/Public/upfile/pic/product/cell-line-new.jpg)
產(chǎn)品概述
產(chǎn)品信息
| 名稱 | NCI-H146 [H146] (人小細胞肺癌細胞) (STR鑒定正確) |
| 別稱 | H146; H-146; NCIH146 |
| 種屬 | 人類 |
| 生長特性 | 懸浮，聚團生長 |
| 細胞形態(tài) | 淋巴母細胞樣 |
| 凍存條件 | 凍存液：55% 基礎培養(yǎng)基+40%FBS+5%DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認） |
培養(yǎng)條件:
氣相：空氣，95%；CO2，5%, 溫度：37℃
|
| 推薦傳代比例 | 1:2-1:3 |
| 推薦換液頻率 | 2-3次/周 |
| 注意事項 | 該細胞為懸浮細胞，請注意離心收集細胞懸液；請勿直接倒掉細胞培養(yǎng)液。 |
參考資料(來源文獻)
| 背景描述 | Derived from the pleural fluid of a patient with small cell lung cancer; the cells express elevated levels of the 4 biochemical markers characteristic of SCLC: neuron-specific enolase, the brain isoenzyme of creatine kinase, L-dopa decarboxylase and bombesin-like immunoreactivity; the cells stain positively for keratin and vimentin but are negative for neurofilament triplet protein; the cells express relatively high amounts of c-myc mRNA, but no amplification of the gene is detected. |
| 年齡（性別） | 男性；59歲 |
| 組織來源 | 肺 |
| 細胞類型 | 腫瘤細胞 |
| 腫瘤類型 | 肺癌細胞 |
| 基因表達情況 | vasopressin negative; oxytocin negative; gastrin releasing peptide negative; vimentin positive by immunostaining; keratin positive by immunostaining; neurofilament triplet protein negative; c-myb mRNA; v-fms mRNA; Ha-ras mRNA; Ki-ras mRNA; N-ras mRNA; c-raf 1 mRNA; myc+; myb+; raf+; ras+; fms+; fes - |
| 保藏機構(gòu) | ATCC; HTB-173 |
STR鑒定
-
STR位點信息
Amelogenin X CSF1PO 11 D2S1338 19 D3S1358 11 D5S818 12 D7S820 9,10 D8S1179 12,14 D13S317 12 D16S539 11 D18S51 15,17 D19S433 13,14 D21S11 30 FGA 23 PentaD 13 PentaE 12 TH01 6,9.3 TPOX 8,11 vWA 14,16 D6S1043 11,19 D12S391 18.3,25 D2S441 10,14 -
STR鑒定圖
-
參考文獻
文獻列表
-
NDRG2 acts as a negative regulator of the progression of small-cell lung cancer through the modulation of the PTEN-AKT-mTOR signalling cascade(2024/03/25)
作者：Zhenchuan Ma, Yuefeng Ma, Jie Feng
期刊：TOXICOLOGY AND APPLIED PHARMACOLOGY
DOI：10.1016/j.taap.2024.116915
影響因子 ：3.800
引用產(chǎn)品：CL-0693
FAQs
Q：{{item.question}}
A：{{item.answer}}
暫無數(shù)據(jù)
產(chǎn)品資料
注：百度瀏覽器無法支持掃一掃功能，請輸入識別碼，獲取相應產(chǎn)品資料
識別碼示意圖
